Intervention for Monitoring of Salt Intake in Hypertensive Patients

NCT05397054 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2022-06-08

No results posted yet for this study

Summary

Sodium is an essential nutrient for humans, but excessive sodium consumption is causally associated with high blood pressure and increase risk of cardiovascular diseases. Dietary sodium consumption of greater than the recommended daily amount of 5 grams of salt or 2,000 mg of sodium is a major risk factor for CVD-related mortality. From recent national survey, Thai people had consumed more than 9.1 g of salt per day, which was nearly two times above WHO reference level. Dietary salt reduction was unsuccessful because of lacking awareness, and the higher threshold to detect salt taste in chronic high salt ingestion. To create awareness in the community, we should be educated, managed the environmental for salt reduction, and used salt meter to detect sodium content in daily food. This study aimed to compare the efficacy of intervention; education, reformulation, environmental change and used salt meter compared with standard treatment alone in terms of salt intake reduction and blood pressure.

Conditions

Interventions

BEHAVIORAL

Education

\- Education: Education about risk of high sodium intake, type of sodium, nutrition ingredients

BEHAVIORAL

Reformulation

\- Reformulation: Dietary recommendation in low sodium intake

BEHAVIORAL

Environmental change

\- Environmental change: Encourage about low sodium intake in community

DEVICE

Salt meter

\- Used salt meter: at least 3 times/wk

BEHAVIORAL

standard treatment

standard treatment

Sponsors & Collaborators

  • World Health Organization

    collaborator OTHER
  • Thai health promotion foundation.

    collaborator UNKNOWN
  • Mahidol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2022-05-30
Completion
2022-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05397054 on ClinicalTrials.gov